STRATA Skin Sciences, Inc.
SSKNDelisted Feb 19, 2026- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001051514
STRATA Skin Sciences, Inc. was delisted on Feb 19, 2026; its insiders filed their last Form 4 on Nov 18, 2025; 14 institutions reported holding it in 13F filings for Q4 2025, worth $1.37M in total; no superinvestor held it.
13F holders, Q2 2025
Institutional positions in STRATA Skin Sciences, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- −2 vs. Q1 2025
- Shares held
- 1.21M
- −22.9K (−1.9%) vs. Q1 2025
- Total value
- $2.77M
- −$480.8K (−14.8%) vs. Q1 2025
- New holders
- 0
- 3 more added
- Sold out
- 2
- 4 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SSKN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 14 | $1.37M |
| Q3 2025 | 17 | $2.37M |
| Q2 2025 | 16 | $2.77M |
| Q1 2025 | 18 | $3.25M |
| Q4 2024 | 16 | $3.51M |
| Q3 2024 | 19 | $3.32M |
| Q2 2024 | 17 | $3.31M |
| Q1 2024 | 24 | $4.21M |
| Q4 2023 | 26 | $6.26M |
| Q3 2023 | 28 | $7.19M |
| Q2 2023 | 29 | $10.7M |
| Q1 2023 | 29 | $11.9M |
| Q4 2022 | 30 | $8.90M |
| Q3 2022 | 27 | $9.79M |
| Q2 2022 | 30 | $10.9M |
| Q1 2022 | 26 | $16.4M |
| Q4 2021 | 23 | $16.2M |
| Q3 2021 | 22 | $18.5M |
| Q2 2021 | 20 | $14.9M |
| Q1 2021 | 17 | $14.2M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding STRATA Skin Sciences, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 5 | $12 | 0.00% | 00.0% | Unchanged |
| Financial Perspectives, Inc | 101 | $231 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 197 | $451 | 0.00% | +176+838.1% | Added |
| MAI Capital Management | 300 | $687 | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 4,465 | $10.2K | 0.00% | −617−12.1% | Reduced |
| UBS Group AG | 7,310 | $16.7K | 0.00% | −3,644−33.3% | Reduced |
| Creative Planning | 10,016 | $22.9K | 0.00% | 00.0% | Unchanged |
| Azzad Asset Management Inc | 12,000 | $27.5K | 0.00% | +1,000+9.1% | Added |
| Tower Research Capital LLC (TRC) | 14,741 | $33.8K | 0.00% | +12,963+729.1% | Added |
| We Are One Seven, LLC | 17,142 | $39.3K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 18,193 | $41.9K | 0.00% | −76−0.4% | Reduced |
| Vanguard Group Inc | 84,632 | $194.7K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 98,030 | $224.5K | 0.00% | −3,800−3.7% | Reduced |
| Nantahala Capital Management, LLC | 403,917 | $925.0K | 0.07% | 00.0% | Unchanged |
| 22NW, LP | 536,995 | $1.23M | 0.90% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −28,841−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −46−100.0% | Sold out |